Cancer Drug for Alzheimer's Treatment Raleigh NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Traci Elizabeth Irwin, MD
Raleigh, NC
Specialties
Neurology
Gender
Female
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1998

Data Provided by:
A Thomas Perkins IV, MD
(919) 782-3456
1540 Sunday Dr
Raleigh, NC
Specialties
Neurology, Sleep Medicine
Gender
Male
Education
Medical School: Northeastern Oh Univs Coll Of Med, Rootstown Oh 44272
Graduation Year: 1991
Hospital
Hospital: Rex Healthcare, Raleigh, Nc; Wake Med Ctr, Raleigh, Nc
Group Practice: Carnes, Kenneth M Phd

Data Provided by:
Steven M Freedman
(919) 782-3456
1540 Sunday Dr
Raleigh, NC
Specialty
Neurology

Data Provided by:
Dr.Nancy Schecter
(919) 872-4410
1631 Midtown Pl # 102
Raleigh, NC
Gender
F
Education
Medical School: Duke Univ Sch Of Med
Year of Graduation: 1979
Speciality
Neurologist
General Information
Hospital: Rex Healthcare, Raleigh, Nc
Accepting New Patients: Yes
RateMD Rating
1.5, out of 5 based on 1, reviews.

Data Provided by:
Vasant N Doshi, MD
Raleigh, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Bj Med Coll, Gujarat Univ, Ahmedabad, Gujarat, India
Graduation Year: 1970

Data Provided by:
Samuel K St Clair
(919) 235-0500
4201 Lake Boone Trl
Raleigh, NC
Specialty
Neurosurgery

Data Provided by:
Lee Wm Mc Lain, MD
(919) 784-8194
Raleigh, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1961

Data Provided by:
Samuel Keith St Clair, MD
(919) 235-0500
4201 Lake Boone Trl Ste 202
Raleigh, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1981

Data Provided by:
Rhonda W Gabr
(919) 782-3456
1540 Sunday Dr
Raleigh, NC
Specialty
Neurology

Data Provided by:
Nancy Schecter, MD
(919) 872-4410
1631 Midtown Pl Apt 102
Raleigh, NC
Specialties
Neurology
Gender
Female
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1979
Hospital
Hospital: Rex Healthcare, Raleigh, Nc; Wake Med Ctr, Raleigh, Nc; Raleigh Community Hospital, Raleigh, Nc

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com